Becker's ASC

Author's posts

St. Luke’s University Health Network adds its 1st female endoscopist

Bethlehem, Pa.-based St. Luke’s University Health Network has added endoscopist Vaishali Patel, MD, to its team of physicians, according to an Aug. 13 report from TapInto.

Why Fresenius offloaded National Cardiovascular Partners to SCA Health 

Optum’s ASC arm, SCA Health, quietly purchased National Cardiovascular Partners from Fresenius Medical Care in December. 

The 10 most affordable places for physicians to live

U.S. News & World Report has released its annual list of the most affordable places to live in 2024 and 2025, with Fort Wayne, Ind., topping the list. 

Doheny Eye Institute names endowed chair

Pasadena, Calif.-based Doheny Eye Institute has tapped ophthalmologist SriniVas Sadda, MD, its current director of artificial intelligence and imaging research, as its endowed chair. 

Feds rule ophthalmologist, practice illegally fired employee who spoke out against COVID-19 violations

An ophthalmologist and his Amsterdam, N.Y.-based practice must pay damages to an employee for illegal retaliation after the employee spoke out about COVID-19 protocol lapses.

10 worst places to live

Louisiana was named the worst state to live in, according to Wallethub’s 2024 Best States To Live In, published Aug. 12.

Steward physician group sold to PE-backed company for $245M 

Nashville, Tenn.-based Rural Healthcare Group, part of private equity firm Kinderhook Industries, agreed to acquire financially troubled Steward Health Care’s 175-physician group for $245 million in cash. 

Private equity's shifting role in healthcare

Becker’s connected with Nilesh Dave, MD, vice president of clinical effectiveness and chief medical officer at Arlington-based Texas Health Resources to discuss the role of profit-driven companies in healthcare.

Employed CRNAs by state

Texas has more certified registered nurse anesthetists than any other state, according to the most recent data from the U.S. Bureau of Labor Statistics, which was updated in April. 

Fecal screenings cut colorectal cancer mortality 33%: Study

Fecal immunochemical tests can reduce colorectal cancer mortality rates by 33%, according to a July 19 study published in JAMA Network Open.